Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Finished Goods Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Dna X (SONM) Liabilities from Discontinued Operations (2024 - 2025)

Dna X's Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 38057000.0 for Q4 2025.

Quarterly results put Liabilities from Discontinued Operations at 38057000.0 for Q4 2025, down 10.98% from a year ago — trailing twelve months through Dec 2025 was 38057000.0 (down 10.98% YoY), and the annual figure for FY2025 was 38057000.0, down 10.98%.
Liabilities from Discontinued Operations for Q4 2025 was 38057000.0 at Dna X, down from 42752000.0 in the prior quarter.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 42752000.0 in Q4 2024 to a low of 38057000.0 in Q4 2025.